The second Nb entering in Phase I is the 68Ga-labeled anti-Macrophage Mannose Receptor (MMR) Nb 3.49, an alpaca-derived Nb targeting the MMR, to enable PET imaging of tumor-associated macrophages (16, 17). Here, MRC1 is linked to neoplasm.